Follow-The-Filings

ALVO Alvotech SA

Health Care COMMON STOCK Equity as of 2026 Q2 among managers we track

Bought by 1 featured manager in 2026 Q2 · 1 sold

  • 2 Owners
  • Max 0.1%
  • $11M
  • 1 add 1 reduce

ALVO (Alvotech SA) is held in 2 featured 13F books as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (0.05%). In 2026 Q2 filings, 1 manager added and 1 trimmed. Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Farallon Capital Management) · not free-float ownership

  1. Farallon Capital Management Add 0.05%
  2. Howard Marks Reduce 0.01%

Who owns ALVO

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management 0.05%, was 0.01% Add +1332.2% 2,859,675 $11M History
Howard Marks - Oaktree Capital Management 0.01% Reduce −59.2% 97,982 $362K History

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
6-K FORM 6-K
6-K FORM 6-K
6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K Period Jun 16, 2026
424B5 —
6-K Period Jun 15, 2026
424B5 —
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
20-F
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K

Financials

US-GAAP annual · as tagged in Form 10-K

newly public · no 10-K financials yet · 424B5

Ownership over time

filing count by report period · click a bar for that quarter’s holders